Drugs / DR-6MP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01433432 | Oct 2011 → Jun 2012 | Crohn disease | Teva GTC | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DR-6MP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01433432 ↗ |
| Known as | 6-Mercaptopurine | “Clinical Efficacy and Safety of Delayed Release 6-Mercaptopurine (DR-6MP) for Targeted Ileal Delivery” NCT01433432 ↗ |